Metagenome next-generation sequencing plays a key role in the diagnosis and selection of effective antibiotics on the treatment of Nocardia pneumonia: a case report

Na Fan, Fang Huang, Jie Zhou, Pengpeng Liu, Mengjie Li, Ye-Ying DingFrontiers in Medicine 2024 · DOI

Abstract

Nocardia disease is a rare opportunistic infection typically seen in immunocompromised patients, but it can be life-threatening even in healthy individuals. This case report describes a 78-year-old male farmer whose lung lesions, initially suspected to be cancerous by both clinicians and artificial intelligence (AI), were correctly identified as Nocardia otitidiscaviarum through metagenome next-generation sequencing (mNGS). This rapid diagnosis allowed for targeted antimicrobial therapy, leading to a full recovery.

The Diagnostic Challenge: A "Great Masquerader"

Pulmonary nocardiosis (PN) often presents a significant diagnostic hurdle. Nocardia, an aerobic, slow-growing bacterium found in soil, frequently mimics lung cancer or tuberculosis on CT scans, showing solid lesions with characteristic "burr signs."

In this case, a previously healthy patient presented with fever and lung lesions. Despite escalating empirical treatments, his condition deteriorated into septic shock. Traditional sputum cultures remained negative. Notably, an AI diagnostic tool (YITU) also misidentified the lesions as malignant, illustrating a critical "blind spot" in software trained primarily on common clinical patterns.

Methods: Leveraging mNGS for Rapid Identification

To resolve the diagnostic deadlock, clinicians performed a needle biopsy of the largest lung lesion, withdrawing pus for analysis. While traditional cultures are slow and often insensitive for Nocardia, the team employed metagenome next-generation sequencing (mNGS).

Figure 2: mNGS results showing the detection of Nocardia otitidiscaviarum at 7,504 copies/mL alongside other viral traces.

Unlike standard cultures, mNGS sequences all nucleic acids in a sample and compares them against vast genomic databases. This "hypothesis-free" approach allows for the identification of rare or fastidious organisms without prior clinical suspicion. In this instance, mNGS provided results in just a few days, whereas traditional cultures can take up to two weeks.

Key Results and Clinical Outcome

The mNGS report identified Nocardia otitidiscaviarum at a concentration of 7,504 copies/mL. Crucially, the report included antibiotic susceptibility data, which is vital given the varying resistance profiles among Nocardia species.

Figure 1: Clinical timeline showing disease progression under empirical therapy followed by radical remission after mNGS-guided targeted treatment.

Based on these findings, the medical team pivoted to a targeted regimen of oral compound sulfamethoxazole and intravenous meropenem. The patient’s fever resolved within 48 hours. Follow-up imaging confirmed the effectiveness of the treatment:

  • One month: Significant reduction in lung shadows.
  • Five months: Complete absorption of the lesions.

Key Insights

  • AI Limitations: The AI's failure to distinguish between rare infection and malignancy highlights the need for clinical oversight and the integration of advanced molecular diagnostics.
  • Diagnostic Speed: The 10-day advantage provided by mNGS over traditional culture was likely life-saving in the context of the patient's septic shock.
  • Precision Medicine: mNGS not only identified the pathogen but also guided the selection of effective antibiotics, moving beyond empirical "broad-spectrum" guesswork.

Limitations and Future Outlook

As a single case report, these findings may not be universally applicable to all PN cases. The primary barriers to widespread mNGS adoption remain its higher cost and limited availability in many clinical settings. However, the authors advocate for the earlier use of mNGS in cases of "fever of unknown origin" or suspected malignancy that fails to respond to initial therapy, potentially transforming the management of complex co-infections.

Summary updated

Abstract

<i>Nocardia</i> disease is an opportunistic infection, the occurrence is rare and mostly occurs in patients with immune deficiency. Even if the patient is immunocompetent, it can still be life-threatening. This case report describes a previously healthy 78-year-old male farmer with lung lesions discovered on a computerized tomography scan. Combined with the patient's history of fever and the results of elevated laboratory markers associated with inflammation, the patient was diagnosed with a lung infection. After escalating empirical broad-spectrum antibiotics, antiviral and antifungal therapy, the patient continued to deteriorate to septic shock. In the meanwhile, the patient's sputum was cultured repeatedly, and no obvious positive pathogenic bacteria were found. Considering the patient was elderly and that these lesions were solid with burr signs, as well as the progression after antimicrobial therapy cancer was considered in the differential diagnosis. Artificial intelligence (YITU, Hangzhou Yitu Medical Technology Limited Company) was also applied, and it also calculated that these lesions were cancerous. The patient received a puncture biopsy of the largest lung lesion. During the puncture pus was withdrawn from largest lung lesion. Culture and metagenome next-generation sequencing (mNGS) detection performed on pus indicated <i>Nocardia otitidiscaviarum</i>. The test report of the mNGS is also attached with a susceptibility report of commonly used clinical antibiotics to this <i>Nocardia</i> spp. Using this result, the patient's disease was quickly controlled after selecting the targeted drug compound sulfamethoxazole and intravenous meropenem for treatment. In view of the high misdiagnosis rate and poor sensitivity of culture for <i>Nocardia</i> spp., this case emphasized mNGS playing a key role in the diagnosis and selection of effective antibiotics for the treatment of <i>Nocardia</i> spp. lung infections.
BibTeX
@inproceedings{fan2024metagenome,
  author = {Na Fan and Fang Huang and Fang Huang and Jie Zhou and Pengpeng Liu and Mengjie Li and Ye-Ying Ding},
  title = {{Metagenome next-generation sequencing plays a key role in the diagnosis and selection of effective antibiotics on the treatment of Nocardia pneumonia: a case report}},
  booktitle = {Frontiers in Medicine},
  year = {2024},
  doi = {10.3389/fmed.2024.1373319},
}
Figure